• Palomid 529 (P529): Dual mTORC1/mTORC2 Inhibitor for Cancer

  2026-06-26

  Palomid 529 (P529) is a potent, small-molecule inhibitor of the PI3K/Akt/mTOR signaling pathway, with pronounced effects on tumor angiogenesis and radiotherapy enhancement. It disrupts both mTORC1 and mTORC2 complexes, displaying broad-spectrum antitumor activity with a GI50 below 35 μM. P529 is valuable in cancer and neural research, as demonstrated by its inhibition of VEGF-driven endothelial proliferation and its role in modulating resistance pathways.

• Triamcinolone (B1859): Technical Guidance for Glucocorticoid

  2026-06-25

  Triamcinolone is a synthetic glucocorticoid agonist used for precise, reproducible modulation of glucocorticoid signaling pathways in research. It is not suitable for diagnostic or clinical applications and requires strict attention to solubility and storage to ensure data quality.

• LY2886721: Precision BACE1 Inhibition and Biomarker Impact i

  2026-06-25

  Explore how LY2886721, a potent oral BACE inhibitor, enables nuanced modulation of amyloid precursor protein processing and Alzheimer’s disease biomarkers. This comprehensive analysis reveals new experimental strategies and scientific insights beyond conventional approaches.

• Targeted SPP1 Inhibition in TAMs Reduces Tumor Burden

  2026-06-24

  This study introduces a phenotypic screening approach to identify small molecule modulators that downregulate SPP1 in tumor-associated macrophages (TAMs). The findings demonstrate that targeted SPP1 inhibition in TAMs leads to significant tumor regression in murine models, offering a promising strategy for reprogramming the tumor microenvironment.

• Preclinical Characterization of Anlotinib: Selective VEGFR2

  2026-06-23

  This study presents a comprehensive preclinical analysis of anlotinib hydrochloride, a highly potent and selective inhibitor of VEGFR2, revealing its superior anti-angiogenic and antitumor activity. The findings highlight anlotinib’s unique efficacy in blocking endothelial migration and angiogenesis, supporting its value for cancer research and clinical development.

• Bsa I (RNase-free): Technical Protocols for DNA Manipulation

  2026-06-23

  Bsa I (RNase-free) enables precise DNA cleavage while preserving RNA integrity, making it well-suited for sensitive molecular biology workflows such as gene cloning and DNA recombinant technology. It is not intended for diagnostic or clinical use and should be reserved for research applications requiring strict RNase-free conditions.

• CUDC-907: Practical Guide for Dual PI3K and HDAC Inhibition

  2026-06-22

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for in vitro research on cancer cell signaling, enabling detailed studies of cell cycle arrest and apoptosis pathways. It is suitable for controlled laboratory workflows but is not validated for diagnostic or clinical applications.

• AEBSF.HCl: Advancing Protease Modulation in Necroptosis and

  2026-06-22

  This thought-leadership article explores the mechanistic and translational significance of AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) as an irreversible serine protease inhibitor. By integrating recent insights into lysosomal membrane permeabilization and protease-driven cell death, we provide actionable guidance for translational researchers seeking to model and modulate necroptosis, amyloid precursor protein processing, and related disease pathways. The article contrasts AEBSF.HCl’s unique capabilities with the current competitive landscape and highlights strategic opportunities for experimental innovation, with direct links to primary research and best-practice protocols.

• EdU Imaging Kits (Cy5): Precision S-Phase DNA Synthesis Meas

  2026-06-21

  EdU Imaging Kits (Cy5) empower researchers with sensitive, morphology-preserving detection of cell proliferation, outperforming BrdU assays in both fluorescence microscopy and flow cytometry. Their click chemistry-driven workflow streamlines S-phase DNA synthesis analysis, now proven invaluable in vascular remodeling models and genotoxicity assessment.

• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency

  2026-06-20

  This study establishes a scalable model using human iPSC-derived sensory neurons to investigate latent infection and reactivation by herpes simplex virus 1 (HSV-1). The platform provides new opportunities to dissect neuron-intrinsic mechanisms of HSV-1 latency and reactivation, bridging a critical gap left by animal models.

• Caspase-3 Fluorometric Assay Kit: Illuminating Apoptosis–Fer

  2026-06-19

  Explore how the Caspase-3 Fluorometric Assay Kit advances apoptosis research by enabling precise cysteine-dependent aspartate-directed protease activity measurement, with unique insights into apoptosis–ferroptosis interplay. This article provides an in-depth analysis, protocol guidance, and practical implications for cancer biology.

• Proteoform-Specific Drug Targeting in Native Cell Signalling

  2026-06-19

  The reference study introduces a mass spectrometry-based approach to characterize proteoform-specific drug interactions within native membrane environments, revealing how post-translational modifications modulate ligand binding. These findings provide a framework for more precise pharmacological targeting, important for both drug safety and efficacy.

• Cy5 Hydrazide: Bridging Protein Carbonylation and Nanotech I

  2026-06-18

  Explore how Cy5 hydrazide (non-sulfonated) empowers translational researchers to precisely quantify oxidative protein modifications, validate nanocarrier-biomolecule interactions, and advance the analytical rigor of emerging platforms like food-grade nutraceutical nanoparticles. Drawing on recent FAST technology breakthroughs, this article offers actionable strategic guidance for leveraging carbonyl-reactive fluorescent dyes in both traditional protein science and next-generation delivery system development.

• Annexin V-FITC/PI Apoptosis Assay Kit: Technical Workflow Gu

  2026-06-18

  The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) enables robust, stage-specific detection of apoptosis and necrosis in cell populations using flow cytometry or fluorescence microscopy. It is ideal for research settings requiring rapid, quantitative assessment of cell death pathways but is not suitable for diagnostic or clinical purposes.

• Spermine Tetrahydrochloride: Precision in Protoplast and NMD

  2026-06-17

  Spermine tetrahydrochloride delivers unmatched membrane stabilization and crystallization performance for advanced protoplast, NMDA receptor, and nanomaterial workflows. Its proven efficacy, high solubility, and experimental flexibility set it apart as the go-to polyamine for researchers seeking reliability and reproducibility.

16282 records 1/1086 page Next 12345 下5页 Last page